When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions
- PMID: 16301701
- PMCID: PMC1283500
- DOI: 10.1503/cmaj.045146
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions
Abstract
Background: Previous research has shown that patient cost-sharing leads to a reduction in overall health resource utilization. However, in Canada, where health care is provided free of charge except for prescription drugs, the converse may be true. We investigated the effect of prescription drug cost-sharing on overall health care utilization among elderly patients with rheumatoid arthritis.
Methods: Elderly patients (> or = 65 years) were selected from a population-based cohort with rheumatoid arthritis. Those who had paid the maximum amount of dispensing fees (200 dollars) for the calendar year (from 1997 to 2000) were included in the analysis for that year. We defined the period during which the annual maximum co-payment had not been reached as the "cost-sharing period" and the one beyond which the annual maximum co-payment had been reached as the "free period." We compared health services utilization patterns between these periods during the 4 study years, including the number of hospital admissions, the number of physician visits, the number of prescriptions filled and the number of prescriptions per physician visit.
Results: Overall, 2968 elderly patients reached the annual maximum cost-sharing amount at least once during the study periods. Across the 4 years, there were 0.38 more physician visits per month (p < 0.001), 0.50 fewer prescriptions filled per month (p = 0.001) and 0.52 fewer prescriptions filled per physician visit (p < 0.001) during the cost-sharing period than during the free period. Among patients who were admitted to the hospital at least once, there were 0.013 more admissions per month during the cost-sharing period than during the free period (p = 0.03).
Interpretation: In a predominantly publicly funded health care system, the implementation of cost-containment policies such as prescription drug cost-sharing may have the unintended effect of increasing overall health utilization among elderly patients with rheumatoid arthritis.
Comment in
-
Prescription drug coverage: an essential service or a fringe benefit?CMAJ. 2005 Nov 22;173(11):1343-4. doi: 10.1503/cmaj.051153. CMAJ. 2005. PMID: 16301702 Free PMC article. No abstract available.
References
-
- Keeler EB, Rolph JE. How cost sharing reduced medical spending of participants in the health insurance experiment. JAMA 1983;249(16):2220-7. - PubMed
-
- Newhouse JP, Manning WG, Morris CN, et al. Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med 1981;305(25):1501-7. - PubMed
-
- Keeler EB. Effects of cost sharing on use of medical services and health. J Med Practice Manage 1992;8(1):11-5.
-
- Shapiro MF, Ware JE Jr, Sherbourne CD. Effects of cost sharing on seeking care for serious and minor symptoms. Results of a randomized controlled trial. Ann Intern Med 1986;104(2):246-51. - PubMed
-
- Joyce GF, Escarce JJ, Solomon MD, et al. Employer drug benefit plans and spending on prescription drugs [published erratum in JAMA 2002;288(19):2409]. JAMA 2002;288(14):1733-9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources